Korean J Obstet Gynecol.  2002 Sep;45(9):1554-1559.

Cordocentesis: Clinical Analysis of 112 Procedures

Affiliations
  • 1Department of Obstetrics and Gynecology, Eulji University hospital, Daejeon, Korea.
  • 2Department of Obstetrics and Gynecology, College of Medicine, Medical Reserach Center, Ewha Womans University, Seoul, Korea.

Abstract


OBJECTIVE
This study was performed to assess the safety and efficacy of the diagnostic cordocentesis in prenatal diagnosis.
METHODS
Between March 1998 and February 2002, percutaneous umblical cord blood samplings under the ultrasonographic guidance were performed in 112 patients. We reviewed the medical records of 112 patients who were performed cordocentesis.
RESULTS
Gestational age ranged between 17 and 36 weeks. The mean maternal age was 29.6 years and the mean gestational age at the time of cordocentesis was 27.8 weeks. Among the patients, 83 cases (74.1%) were done with the indication of abnormal sonographic finding and followed by rapid karyotyping. Pure fetal blood was successfully obtained in 105 cases of 112 cordocentesis (93.8%). 99 cases (88.4%) were done successfully at the first attempt. Chromosomal abnormalities were found in 9 of 103 fetuses (8.7%). Abnormal chromosomal patterns were found in 8 of 70 fetuses (11.4%) with structural anomalies detected by ultrasonography. The procedure-related complication, fetal bradycardia occured in 3 cases (2.7%).
CONCLUSION
We conclude that cordocentesis is a useful, relatively safe, and effective procedure for prenatal diagnosis.

Keyword

Cordocentesis

MeSH Terms

Bradycardia
Chromosome Aberrations
Cordocentesis*
Fetal Blood
Fetus
Gestational Age
Humans
Karyotyping
Maternal Age
Medical Records
Prenatal Diagnosis
Ultrasonography
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr